Healthcare Stocks

Why is Motus GI Holdings (MOTS) stock gaining traction today?

  • September 29, 2022 07:20 AM PDT | Rupam Roy
 Why is Motus GI Holdings (MOTS) stock gaining traction today?

The MOTS stock soared more than 78 per cent in the morning trading on September 29, gaining attention from several investors.

Read More...
Novartis AG (NVS) stock rises after FDA’s accelerated drug approval

Novartis AG (NVS) stock rises after FDA’s accelerated drug approval

Novartis AG received FDA's accelerated approval for the combination of its two drugs, Tafinlar and Mekinist as first tumor-agnostic indication.

Read More...
Seagen (SGEN) stock roared 17% higher on Merck’s (MRK) buyout plan

Seagen (SGEN) stock roared 17% higher on Merck’s (MRK) buyout plan

Highlights: Washington-based Seagen Inc. (NASDAQ: SGEN) stock rose 16.76% on Friday. Merck & Company, Inc. (MRK) is considering buying the biotech firm.  However, their talks are not yet conclusive. Washington-based Seagen Inc. (...

Read More...
Why Day One Biopharmaceuticals (DAWN) stock shot up 135%?

Why Day One Biopharmaceuticals (DAWN) stock shot up 135%?

Highlights: Day One Biopharmaceuticals Inc company develops therapies for cancers.  It announced positive initial results from its Phase 2 clinical trial on Monday. It expects the topline results from the study by Q1 of 2023. Day One...

Read More...
Cogent Biosciences (COGT) stock soars 101% on positive trial data

Cogent Biosciences (COGT) stock soars 101% on positive trial data

Highlights: Cogent Biosciences, Inc. (NASDAQ: COGT) develops therapies for genetic diseases. The company went public on March 26, 2018.  On Friday, it reported positive Phase 2 clinical trial data for ‘Bezuclastinib’. Sha...

Read More...
Top healthcare stocks to explore in June: JNJ, LLY, ABBV, MRK & BMY

Top healthcare stocks to explore in June: JNJ, LLY, ABBV, MRK & BMY

Highlights: Johnson & Johnson (NYSE: JNJ) revenue increased by 5% YoY in Q1, FY22. Merck & Company, Inc. (NYSE: MRK) revenue rose 50% YoY in Q1, FY22. Bristol-Myers Squibb Company (NYSE: BMY) stock returned over 21% gains YTD. The...

Read More...
Moderna (MRNA) says Omicron-targeted COVID shot shows better response

Moderna (MRNA) says Omicron-targeted COVID shot shows better response

  • June 08, 2022 06:29 AM PDT | Reuters

Moderna Inc said on Wednesday a new version of its coronavirus vaccine produced a better immune response against Omicron than the original shot, as the drugmaker pursues a booster against a surge in infections in the fall season. The vaccine, whic...

Read More...
Becton, Dickinson & Co (BDX) to acquire Parata Systems for US$1.525 bn

Becton, Dickinson & Co (BDX) to acquire Parata Systems for US$1.525 bn

Highlights: Becton, Dickinson & Company or BD (NYSE: BDX) to acquire Parata Systems for US$1.525 billion. The deal is likely to close by the end of the first half of fiscal 2023 for BD. The pharmacy automation market is set to grow approxi...

Read More...
Turning Point (TPTX) stock zooms 115% on Bristol Myers’ (BMY) acquisition

Turning Point (TPTX) stock zooms 115% on Bristol Myers’ (BMY) acquisition

Highlights  Turning Point Therapeutics, Inc. (TPTX) is focused on precision oncology therapy. It was founded in 2013 and launched its IPO in April 2019.  Bristol Myers Squibb is acquiring Turning Point for US$4.1 billion in equity va...

Read More...
Why Immix Biopharma Inc (IMMX) stock soared 55% on Friday?

Why Immix Biopharma Inc (IMMX) stock soared 55% on Friday?

The Immix Biopharma Inc. (NASDAQ: IMMX) stock surged 55% after announcing positive results for its lead drug candidate IMX-110 in the first treatment cycle. The stock traded at US$2.5425 at 1:00 pm ET on Friday. The company said that its lead dru...

Read More...
MCK to ABC: 5 healthcare stocks that returned strong 1-year, YTD gains

MCK to ABC: 5 healthcare stocks that returned strong 1-year, YTD gains

Highlights  Bristol-Myers Squibb (NYSE: BMY) has a P/E ratio of 27.0 and a dividend yield of 2.84%. Merck & Company, Inc.'s (NYSE: MRK) P/E ratio is 16.02, and the dividend yield is 3.09%. AbbVie Inc.'s (NYSE: ABBV) dividend yield is ...

Read More...

Frequently Asked Questions

Healthcare stocks are companies involved in the healthcare industry. These companies are engaged in manufacturing. Various pharmaceutical products, including medicine, medical devices, medical care through hospitals and medical centres, health insurance, etc. Despite stock market risks, healthcare stocks can provide substantial returns in the long run. The healthcare sector has been one of the top-performing sectors over the past year. The covid-19 pandemic has accelerated its growth. Some of the top healthcare stocks include Walgreens Boots Alliance Inc. (WBA), Sage Therapeutics Inc. (SAGE), Bio-Rad Laboratories Inc. (BIO), Pfizer Inc, Moderna Inc, etc.

The healthcare sector is one of the largest and most complex sectors in the US, which is comprised of various companies that engage in a wide range of healthcare-related operations. Some of the top healthcare stocks in the US are as follows: UnitedHealth Group Inc. (UNH) Johnson & Johnson (JNJ) Pfizer Inc (PFE) Abbvie Inc (ABBV) Eli Lilly and Co (LLY)

The healthcare sector is one of the centers of attraction of investors in recent days, especially considering the growth potentials of the companies. Some of the best US healthcare stocks are as follows, that maintained has maintained a steady momentum even amid the market downturn. Johnson & Johnson (JNJ) Abbvie Inc (ABBV) Eli Lilly and Co (LLY) Merck & Co Inc (MRK) Bristol-Myers Squibb Co (BMY)

AI healthcare stocks are companies that use artificial intelligence to provide tailor-made products and services to the healthcare industry. The innovation in AI healthcare companies is rapidly transforming the industry. Their help to understand and classify clinical documentation, clinical notes on patients, and insight into methods for better results.